Sanders Morris Harris

Founded in 1991, Behrman Capital is a private equity investment firm with more than $2.0 billion of capital under management. The firm invests in the management buyout, leveraged buildup and recapitalization of established growth companies. Behrman Capital specializes in the health care, defense, specialty manufacturing, business-to-business outsourcing and information technology industries. It partners with various institutions, including The National Geographic Society, BankAmerica, the Bank of Nova Scotia, AXA, Partners Group, Hamilton Lane Fund of Funds, Illinois State Board and Wilshire Associates. Behrman Capital makes investments in Ark Holding Company, Athena Diagnostics, Esoterix, Tandem Health Care, and Wil Research Laboratories.

Macellum Capital is a financial investment firm located in New York, NY, known for its strategic approach to investing in various market sectors. The firm is dedicated to generating long-term value through active engagement and collaboration with its portfolio companies. With a focus on delivering tailored investment solutions, Macellum Capital emphasizes a disciplined investment philosophy and a commitment to achieving superior returns. The firm prioritizes transparency and ethical practices in all its endeavors, ensuring strong relationships with stakeholders. Generated from the website

Scopia Capital LLC is a New York based firm that provides investment management with a long/short, value driven, market-neutral approach, as well as long only investment management to institutional investors. The company was founded in 2001 by Matt Sirovich and Jeremy Mindich. We believe that our investment style is unusual in that we combine fundamentally focused, deep due diligence and a concentrated portfolio of high conviction long and short positions with the discipline of market neutrality. As of November 30th 2010, Scopia had $1.6 billion in assets under management and an outstanding team of 24 employees. Our management company has been registered as an investment adviser with the Securities and Exchange Commission since 2003. For further information please contact (212 ) 370-0303 or email us at investors@scopiacapital.com.